Annual EBIT
-$25.87 M
-$9.35 M-56.58%
31 December 2023
Summary:
Trinity Biotech annual earnings before interest & taxes is currently -$25.87 million, with the most recent change of -$9.35 million (-56.58%) on 31 December 2023. During the last 3 years, it has fallen by -$24.78 million (-2256.47%). TRIB annual EBIT is now -141.83% below its all-time high of $64.67 million.TRIB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.71 M
-$244.00 K-16.64%
30 September 2024
Summary:
Trinity Biotech quarterly earnings before interest & taxes is currently -$1.71 million, with the most recent change of -$244.00 thousand (-16.64%) on 30 September 2024. Over the past year, it has increased by +$2.40 million (+58.40%). TRIB quarterly EBIT is now -103.36% below its all-time high of $50.84 million, reached on 30 June 2010.TRIB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$10.28 M
+$2.40 M+18.94%
30 September 2024
Summary:
Trinity Biotech TTM earnings before interest & taxes is currently -$10.28 million, with the most recent change of +$2.40 million (+18.94%) on 30 September 2024. Over the past year, it has increased by +$33.77 million (+76.67%). TRIB TTM EBIT is now -116.44% below its all-time high of $62.51 million, reached on 31 March 2011.TRIB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.6% | +58.4% | +76.7% |
| 3 y3 years | -2256.5% | -157.7% | -100.0% |
| 5 y5 years | -42.9% | -219.0% | +46.5% |
TRIB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -516.6% | at low | -157.7% | +92.0% | -391.7% | +78.5% |
| 5 y | 5 years | -516.6% | at low | -118.8% | +93.8% | -391.7% | +78.5% |
| alltime | all time | -141.8% | +67.5% | -103.4% | +99.0% | -116.4% | +93.8% |
Trinity Biotech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.71 M(+16.6%) | -$10.28 M(-18.9%) |
| June 2024 | - | -$1.47 M(-50.9%) | -$12.68 M(-51.2%) |
| Mar 2024 | - | -$2.99 M(-27.4%) | -$26.00 M(-2.9%) |
| Dec 2023 | -$25.87 M(+56.6%) | -$4.11 M(+0.1%) | -$26.78 M(-39.2%) |
| Sept 2023 | - | -$4.11 M(-72.2%) | -$44.05 M(-7.7%) |
| June 2023 | - | -$14.79 M(+292.8%) | -$47.74 M(+37.2%) |
| Mar 2023 | - | -$3.77 M(-82.4%) | -$34.80 M(+8.6%) |
| Dec 2022 | -$16.52 M(-366.1%) | -$21.38 M(+174.0%) | -$32.03 M(+122.4%) |
| Sept 2022 | - | -$7.80 M(+321.7%) | -$14.40 M(+295.7%) |
| June 2022 | - | -$1.85 M(+85.4%) | -$3.64 M(+557.0%) |
| Mar 2022 | - | -$998.00 K(-73.4%) | -$554.00 K(-115.7%) |
| Dec 2021 | $6.21 M(-665.6%) | -$3.75 M(-226.7%) | $3.52 M(-168.6%) |
| Sept 2021 | - | $2.96 M(+139.6%) | -$5.14 M(-619.4%) |
| June 2021 | - | $1.24 M(-59.9%) | $989.00 K(+286.3%) |
| Mar 2021 | - | $3.08 M(-124.8%) | $256.00 K(-123.3%) |
| Dec 2020 | -$1.10 M(-95.3%) | -$12.41 M(-236.6%) | -$1.10 M(-93.3%) |
| Sept 2020 | - | $9.09 M(+1706.8%) | -$16.33 M(-31.9%) |
| June 2020 | - | $503.00 K(-70.8%) | -$23.98 M(+3.6%) |
| Mar 2020 | - | $1.72 M(-106.2%) | -$23.15 M(-1.1%) |
| Dec 2019 | -$23.41 M(+29.3%) | -$27.65 M(-2023.9%) | -$23.41 M(+21.9%) |
| Sept 2019 | - | $1.44 M(+7.4%) | -$19.21 M(-0.1%) |
| June 2019 | - | $1.34 M(-8.4%) | -$19.24 M(+3.1%) |
| Mar 2019 | - | $1.46 M(-106.2%) | -$18.65 M(+3.0%) |
| Dec 2018 | -$18.10 M(-47.5%) | -$23.45 M(-1761.7%) | -$18.10 M(-47.3%) |
| Sept 2018 | - | $1.41 M(-26.6%) | -$34.38 M(+1.0%) |
| June 2018 | - | $1.92 M(-4.4%) | -$34.05 M(+0.3%) |
| Mar 2018 | - | $2.01 M(-105.1%) | -$33.94 M(-1.5%) |
| Dec 2017 | -$34.47 M(-6.1%) | -$39.72 M(-2382.9%) | -$34.47 M(-668.1%) |
| Sept 2017 | - | $1.74 M(-14.2%) | $6.07 M(-16.4%) |
| June 2017 | - | $2.03 M(+36.6%) | $7.26 M(-7.1%) |
| Mar 2017 | - | $1.49 M(+82.4%) | $7.81 M(-6.7%) |
| Dec 2016 | -$36.70 M(-235.9%) | $814.00 K(-72.2%) | $8.37 M(-29.0%) |
| Sept 2016 | - | $2.93 M(+13.6%) | $11.79 M(-47.7%) |
| June 2016 | - | $2.58 M(+26.1%) | $22.55 M(-6.2%) |
| Mar 2016 | - | $2.04 M(-51.7%) | $24.05 M(-8.7%) |
| Dec 2015 | $27.00 M(+73.8%) | $4.24 M(-69.0%) | $26.34 M(+10.7%) |
| Sept 2015 | - | $13.69 M(+235.4%) | $23.80 M(+61.2%) |
| June 2015 | - | $4.08 M(-5.9%) | $14.77 M(-3.6%) |
| Mar 2015 | - | $4.34 M(+155.1%) | $15.32 M(-1.4%) |
| Dec 2014 | $15.54 M(+51.3%) | $1.70 M(-63.5%) | $15.53 M(+46.7%) |
| Sept 2014 | - | $4.65 M(+0.4%) | $10.59 M(-3.3%) |
| June 2014 | - | $4.63 M(+1.9%) | $10.95 M(+4.8%) |
| Mar 2014 | - | $4.55 M(-240.2%) | $10.45 M(+1.7%) |
| Dec 2013 | $10.27 M(-47.2%) | -$3.24 M(-164.7%) | $10.27 M(-44.3%) |
| Sept 2013 | - | $5.01 M(+21.3%) | $18.43 M(+0.4%) |
| June 2013 | - | $4.13 M(-5.4%) | $18.37 M(-4.0%) |
| Mar 2013 | - | $4.37 M(-11.2%) | $19.14 M(-1.6%) |
| Dec 2012 | $19.45 M(+6.8%) | $4.92 M(-0.5%) | $19.45 M(+1.1%) |
| Sept 2012 | - | $4.95 M(+0.9%) | $19.23 M(+1.6%) |
| June 2012 | - | $4.90 M(+4.8%) | $18.93 M(+2.1%) |
| Mar 2012 | - | $4.68 M(-0.5%) | $18.55 M(+1.9%) |
| Dec 2011 | $18.21 M(-70.6%) | $4.70 M(+1.2%) | $18.21 M(+3.2%) |
| Sept 2011 | - | $4.65 M(+2.9%) | $17.65 M(+9.0%) |
| June 2011 | - | $4.52 M(+4.1%) | $16.19 M(-74.1%) |
| Mar 2011 | - | $4.34 M(+4.9%) | $62.51 M(+1.1%) |
| Dec 2010 | $61.85 M(+338.5%) | $4.14 M(+29.5%) | $61.85 M(+1.1%) |
| Sept 2010 | - | $3.19 M(-93.7%) | $61.21 M(-0.9%) |
| June 2010 | - | $50.84 M(+1279.2%) | $61.74 M(+318.6%) |
| Mar 2010 | - | $3.69 M(+5.6%) | $14.75 M(+4.6%) |
| Dec 2009 | $14.11 M(-117.7%) | $3.49 M(-6.5%) | $14.11 M(-118.8%) |
| Sept 2009 | - | $3.73 M(-2.9%) | -$75.00 M(-2.2%) |
| June 2009 | - | $3.84 M(+26.3%) | -$76.70 M(-1.9%) |
| Mar 2009 | - | $3.04 M(-103.6%) | -$78.20 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | -$79.51 M(+175.0%) | -$85.62 M(-4317.5%) | -$79.45 M(-52.2%) |
| Sept 2008 | - | $2.03 M(-13.3%) | -$166.37 M(+24.5%) |
| June 2008 | - | $2.34 M(+30.8%) | -$133.67 M(+1.0%) |
| Mar 2008 | - | $1.79 M(-101.0%) | -$132.31 M(+1.2%) |
| Dec 2007 | -$28.91 M(-1589.7%) | -$172.53 M(-596.7%) | -$130.79 M(-405.1%) |
| Sept 2007 | - | $34.73 M(+839.3%) | $42.87 M(+286.6%) |
| June 2007 | - | $3.70 M(+11.7%) | $11.09 M(+202.3%) |
| Mar 2007 | - | $3.31 M(+195.5%) | $3.67 M(+88.9%) |
| Dec 2006 | $1.94 M(-70.7%) | $1.12 M(-62.1%) | $1.94 M(-39.5%) |
| Sept 2006 | - | $2.96 M(-179.5%) | $3.21 M(+53.5%) |
| June 2006 | - | -$3.72 M(-334.7%) | $2.09 M(-70.8%) |
| Mar 2006 | - | $1.59 M(-33.6%) | $7.15 M(+2.1%) |
| Dec 2005 | $6.62 M(+12.4%) | $2.39 M(+29.7%) | $7.00 M(+7.5%) |
| Sept 2005 | - | $1.84 M(+37.9%) | $6.51 M(+1.3%) |
| June 2005 | - | $1.33 M(-7.2%) | $6.43 M(-1.0%) |
| Mar 2005 | - | $1.44 M(-24.2%) | $6.49 M(+10.2%) |
| Dec 2004 | $5.89 M(-39.1%) | $1.90 M(+8.1%) | $5.89 M(-14.0%) |
| Sept 2004 | - | $1.76 M(+25.4%) | $6.85 M(-8.4%) |
| June 2004 | - | $1.40 M(+66.9%) | $7.48 M(-9.7%) |
| Mar 2004 | - | $839.00 K(-70.6%) | $8.29 M(-14.3%) |
| Dec 2003 | $9.67 M(+48.2%) | $2.86 M(+19.9%) | $9.67 M(+14.2%) |
| Sept 2003 | - | $2.38 M(+8.1%) | $8.47 M(+9.1%) |
| June 2003 | - | $2.21 M(-0.8%) | $7.76 M(+7.8%) |
| Mar 2003 | - | $2.22 M(+34.2%) | $7.20 M(+10.3%) |
| Dec 2002 | $6.52 M(+12.2%) | $1.66 M(-1.4%) | $6.52 M(-6.6%) |
| Sept 2002 | - | $1.68 M(+2.4%) | $6.99 M(+4.4%) |
| June 2002 | - | $1.64 M(+5.9%) | $6.70 M(+7.9%) |
| Mar 2002 | - | $1.55 M(-26.9%) | $6.20 M(+6.7%) |
| Dec 2001 | $5.82 M(-10.6%) | $2.12 M(+52.8%) | $5.82 M(+7.8%) |
| Sept 2001 | - | $1.39 M(+20.7%) | $5.39 M(-5.9%) |
| June 2001 | - | $1.15 M(-0.9%) | $5.73 M(-6.9%) |
| Mar 2001 | - | $1.16 M(-31.7%) | $6.16 M(-5.4%) |
| Dec 2000 | $6.50 M(+25.9%) | $1.70 M(-1.6%) | $6.50 M(+3.0%) |
| Sept 2000 | - | $1.73 M(+9.9%) | $6.32 M(+5.4%) |
| June 2000 | - | $1.57 M(+4.1%) | $5.99 M(+6.6%) |
| Mar 2000 | - | $1.51 M(-0.2%) | $5.62 M(+6.8%) |
| Dec 1999 | $5.17 M(+80.0%) | $1.51 M(+7.8%) | $5.27 M(+11.5%) |
| Sept 1999 | - | $1.40 M(+16.6%) | $4.72 M(+17.5%) |
| June 1999 | - | $1.20 M(+4.5%) | $4.02 M(+21.1%) |
| Mar 1999 | - | $1.15 M(+18.6%) | $3.32 M(-56.7%) |
| Dec 1998 | $2.87 M(+474.0%) | $970.00 K(+38.6%) | $7.67 M(-253.4%) |
| Sept 1998 | - | $700.00 K(+40.0%) | -$5.00 M(+614.3%) |
| June 1998 | - | $500.00 K(-90.9%) | -$700.00 K(-124.1%) |
| Mar 1998 | - | $5.50 M(-147.0%) | $2.90 M(+480.0%) |
| Dec 1997 | $500.00 K(-171.4%) | -$11.70 M(-334.0%) | $500.00 K(-92.4%) |
| Sept 1997 | - | $5.00 M(+22.0%) | $6.60 M(+88.6%) |
| June 1997 | - | $4.10 M(+32.3%) | $3.50 M(+288.9%) |
| Mar 1997 | - | $3.10 M(-155.4%) | $900.00 K(-228.6%) |
| Dec 1996 | -$700.00 K(-61.1%) | -$5.60 M(-394.7%) | -$700.00 K(-83.7%) |
| Sept 1996 | - | $1.90 M(+26.7%) | -$4.30 M(+16.2%) |
| June 1996 | - | $1.50 M(0.0%) | -$3.70 M(+32.1%) |
| Mar 1996 | - | $1.50 M(-116.3%) | -$2.80 M(+55.6%) |
| Dec 1995 | -$1.80 M(-33.3%) | -$9.20 M(-468.0%) | -$1.80 M(-124.3%) |
| Sept 1995 | - | $2.50 M(+4.2%) | $7.40 M(+12.1%) |
| June 1995 | - | $2.40 M(-4.0%) | $6.60 M(+11.9%) |
| Mar 1995 | - | $2.50 M(+47.1%) | $5.90 M(-395.0%) |
| Dec 1994 | -$2.70 M(-35.7%) | - | - |
| Aug 1994 | - | $1.70 M(0.0%) | -$2.00 M(-35.5%) |
| May 1994 | - | $1.70 M(-128.3%) | -$3.10 M(-26.2%) |
| Feb 1994 | - | -$6.00 M(-1100.0%) | -$4.20 M(-333.3%) |
| Feb 1994 | -$4.20 M | - | - |
| Nov 1993 | - | $600.00 K(0.0%) | $1.80 M(+50.0%) |
| Aug 1993 | - | $600.00 K(0.0%) | $1.20 M(+100.0%) |
| May 1993 | - | $600.00 K | $600.00 K |
FAQ
- What is Trinity Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Trinity Biotech?
- What is Trinity Biotech annual EBIT year-on-year change?
- What is Trinity Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Trinity Biotech?
- What is Trinity Biotech quarterly EBIT year-on-year change?
- What is Trinity Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Trinity Biotech?
- What is Trinity Biotech TTM EBIT year-on-year change?
What is Trinity Biotech annual earnings before interest & taxes?
The current annual EBIT of TRIB is -$25.87 M
What is the all time high annual EBIT for Trinity Biotech?
Trinity Biotech all-time high annual earnings before interest & taxes is $64.67 M
What is Trinity Biotech annual EBIT year-on-year change?
Over the past year, TRIB annual earnings before interest & taxes has changed by -$9.35 M (-56.58%)
What is Trinity Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of TRIB is -$1.71 M
What is the all time high quarterly EBIT for Trinity Biotech?
Trinity Biotech all-time high quarterly earnings before interest & taxes is $50.84 M
What is Trinity Biotech quarterly EBIT year-on-year change?
Over the past year, TRIB quarterly earnings before interest & taxes has changed by +$2.40 M (+58.40%)
What is Trinity Biotech TTM earnings before interest & taxes?
The current TTM EBIT of TRIB is -$10.28 M
What is the all time high TTM EBIT for Trinity Biotech?
Trinity Biotech all-time high TTM earnings before interest & taxes is $62.51 M
What is Trinity Biotech TTM EBIT year-on-year change?
Over the past year, TRIB TTM earnings before interest & taxes has changed by +$33.77 M (+76.67%)